Advanced therapeutics, such as cell engineering, gene therapy, and immune engineering, comprise the next generation of life-enhancing and curative interventions. As new therapies gain approval, the demand for skilled professionals in biopharmaceutical manufacturing, such as cell and gene therapy production, will continue to rise. For those interested in joining this growing workforce, Drexel University’s new programs provide fundamental knowledge and skills to prepare for careers in this rapidly evolving area. Graduating students work in industry in fields such as biomanufacturing, pharmaceuticals and biotechnology, and healthcare, or continue in academic careers (PhD) or medical schools. 

Read the report of the Chamber of Commerce for Greater Philadelphia on the region's journey to become a nationally recognized Cell and Gene Therapy hub:Leading the way - Cell and Gene Therapy in the Greater Philadelphia Area.

Minors and Accelerated BS/MS Degrees

Undergraduate minors offered by the School of Biomedical Engineering, Science and Health Systems (BIOMED) and the Department of Biology, College of Arts and Sciences (CoAS)

Accelerated degrees offered by the School of Biomedical Engineering, Science and Health Systems (BIOMED) and the Department of Biology, College of Arts and Sciences (CoAS)

These are accelerated 4+1 program that allows students to complete a BS in Biomedical Engineering or Biological Sciences and a Master in Advanced Therapeutics in 5 years. The BS degrees provide the scientific, technical, and analytical skills for solving human health problems, and the MS degree provides the specialization and lab skills pertaining to immune engineering, cell engineering, gene therapy and biomanufacturing.

MS Degrees

Graduate degree offered by the School of Biomedical Engineering, Science and Health Systems (BIOMED) and the Department of Biology, College of Arts and Sciences (CoAS), and the College of Medicine (CoM)

The MS degree program in Advanced Therapeutics provides a unique multidisciplinary practical graduate education providing foundations and best practices for research and development of the next generation of therapeutics, such as immune engineering, cellular and genetic therapies, targeted drug delivery, and personalized medicine, as well as pharmacogenomics. For those interested in joining this growing workforce, our new program provides fundamental knowledge and lab skills pertaining to cell engineering and gene therapy, manufacturing, and the option to choose a 6-month graduate co-op. Students with biomedical engineering and health sciences undergraduate backgrounds are welcome.

Online Degrees

Online graduate degree and certificate offered by the Graduate School of Biomedical Sciences and Professional Studies in the College of Medicine (CoM)

• MS in Biomedicine and Cell and Gene Therapy
• Post-BS Certificate in Regulatory Affairs for Cell and Gene Therapy

Drexel's MS in Biomedicine and Cell and Gene Therapy degree is unique, as students are able to take courses in both Drexel's College of Medicine and College of Engineering. Students are taught by both medical school professors and engineering professors; our program operates at the intersection of these two fields, and our graduates can talk to professionals in both fields. Another unique feature of our curriculum is that every MS student takes a capstone course on the commercialization of a novel biomedical technology and works with a team to develop a commercialization plan. Students also have the option of completing a virtual industry internship to build their resume and gain experience. The Regulatory Affairs for Cell and Gene Therapy post-baccalaureate certificate program trains leaders for this growing discipline and prepares them to bring new therapeutics to market.